SpringWorks Therapeutics (SWTX) Stock Chart & Stock Price History $46.20 -0.01 (-0.01%) As of 12:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SpringWorks Therapeutics Stock Price Performance 5 Day Performance+3.50%1 Month Performance-0.51%3 Month Performance+23.43%6 Month Performance+51.16%Year-To-Date Performance+28.11%1 Year Performance+6.77% Receive SWTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SWTX Stock Chart for Friday, May, 2, 2025 SWTX Chart by TradingView SpringWorks Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$46.30$46.21-0.19%$46.31$46.056.44 million shs$3.47 billion04/30/2025$46.24$46.30+0.13%$46.30$46.1610.80 million shs$3.47 billion04/29/2025$46.18$46.24+0.13%$46.25$46.1414.12 million shs$3.47 billion04/28/2025$44.72$46.18+3.26%$46.20$46.0679.82 million shs$3.46 billion04/25/2025$44.93$44.72-0.47%$45.01$44.197.81 million shs$3.35 billion04/24/2025$41.27$44.93+8.88%$46.21$40.478.84 million shs$3.37 billion04/23/2025$40.50$41.27+1.89%$42.15$40.341.91 million shs$3.09 billion04/22/2025$37.06$40.50+9.28%$40.80$37.903.71 million shs$3.03 billion04/21/2025$37.89$37.06-2.19%$38.28$36.521.20 million shs$2.78 billion04/18/2025$37.89$37.89$39.03$37.341.45 million shs$2.84 billion Get the Latest News and Ratings for SWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$37.74$37.89+0.39%$39.03$37.341.45 million shs$2.84 billion04/16/2025$37.59$37.74+0.40%$37.89$36.081.68 million shs$2.83 billion04/15/2025$37.46$37.59+0.35%$38.77$36.961.49 million shs$2.82 billion04/14/2025$36.47$37.46+2.71%$37.99$36.081.25 million shs$2.81 billion04/11/2025$34.43$36.47+5.93%$36.53$33.562.04 million shs$2.73 billion04/10/2025$37.12$34.43-7.25%$36.17$33.242.25 million shs$2.58 billion04/09/2025$35.71$37.12+3.95%$38.60$32.833.48 million shs$2.78 billion04/09/2025$35.71$37.12+3.95%$38.60$32.833.48 million shs$2.78 billion04/08/2025$36.99$35.71-3.46%$38.90$35.072.12 million shs$2.68 billion04/08/2025$36.99$35.71-3.46%$38.90$35.072.12 million shs$2.68 billion04/07/2025$39.09$36.99-5.37%$39.90$35.723.13 million shs$2.77 billion04/04/2025$43.07$39.09-9.24%$42.44$38.573.28 million shs$2.93 billion04/03/2025$46.52$43.07-7.42%$46.16$43.051.78 million shs$3.23 billion04/02/2025$41.88$46.52+11.08%$46.95$41.304.56 million shs$3.49 billion04/01/2025$44.13$41.88-5.10%$44.18$40.982.59 million shs$3.14 billion Related Companies Genmab A/S Stock Chart Dr. Reddy's Laboratories Stock Chart Moderna Stock Chart Ascendis Pharma A/S Stock Chart Viatris Stock Chart Qiagen Stock Chart Roivant Sciences Stock Chart Revolution Medicines Stock Chart Lantheus Stock Chart BridgeBio Pharma Stock Chart Receive SWTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SWTX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SpringWorks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SpringWorks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
